Follow-up results of a randomized, double-blind, phase III, multi-center study to evaluate the safety and efficacy of BF-200 ALA versus placebo in field-directed treatment of mild to moderate AK with photodynamic therapy when using narrowband red light. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, p. S49, 2019. DOI: 10.25251/skin.3.supp.49. Disponível em: https://skin.dermsquared.com/skin/article/view/777. Acesso em: 21 apr. 2026.